ACT-774312

N/A

Report date: 2025/12/02 20:00:12
NME

Base Information

Drug NameACT-774312
Drug Alias NameACT-774312
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin D2 receptor 2 antagonists
TargetsProstaglandin D2 receptor 2
Therapy Area/IndicationsNasal Polyps
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumGermany
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIdorsia Pharmaceuticals LtdActelion Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIdorsia Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsNasal Polyps

Other Information

ATC CodeN/A
Related LinksN/A